| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |